Management and Outcome in Patients With Klatskin-Mimicking Lesions of the Biliary Tree

Journal of Gastrointestinal Surgery

Volumn 10, Issue 8, 2006, Pages 1144-1150

  Uhlmann, Dirk ^a   Wiedmann, Marcus ^a   Schmidt, Frank ^a   Kluge, Regine ^a   Tannapfel, Andrea ^a   Berr, Frieder ^a   Hauss, Johann ^a   Witzigmann, Helmut ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

benign; Extrahepatic bile duct; Klatskin mimicking; stricture

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; BIOPSY; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HEPATIC DUCT; HUMAN; KLATSKIN TUMOR; LAPAROSCOPY; LIVER RESECTION; MALE; METHODOLOGY; MIDDLE AGED; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; BILE DUCT NEOPLASMS; BIOPSY; CHOLECYSTECTOMY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748463389     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2006.04.003     Document Type: Article

References (37)

1. Chamberlain R.S., and Blumgart L.H. Hilar cholangiocarcinoma: A review and commentary. Ann Surg Oncol 7 (2000) 55-66
2. Verbeek P.C.M., van Leeuwen D.J., de Wit L.T., Reeders J.W., Smits N.J., Bosma A., Huibregtse K., and van der Heyde M.N. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 112 (1992) 866-871
3. Gerhards M.F., Vos P., van Gulik T.M., Rauws E.A., Bosma A., and Gouma D.J. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 88 (2001) 48-51
4. Knoefel W.T., Prenzel K.L., Peiper M., Hosch S.B., Gundlach M., Eisenberger C.F., Strate T., Scheunemann P., Rogiers X., and Izbicki J.R. Klatskin tumors and Klatskin mimicking lesions of the biliary tree. EJSO 29 (2003) 658-661
5. Khan S.A., Davidson B.R., Goldin R., et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut 51 Suppl 6 (2002) VI1-VI9
6. Qualman S.J., Haupt H.M., Bauer T.W., and Taxy J.B. Adenocarcinoma of the hepatic duct junction. A reappraisal of the histologic criteria of malignancy. Cancer 53 (1984) 1545-1551
7. Hoang M.P., Murakata L.A., Padilla-Rodriguez A.L., and Albores-Saavedra J. Metaplastic lesions of the extrahepatic bile ducts: A morphologic and immunohistochemical study. Mod Pathol 14 (2001) 1119-1125
8. Lowe V.J., Fletcher J.W., and Gobar L. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16 (1998) 1075-1084
9. Kau R.J., Alexiou C., Laubenbacher C., Ziegler S., Schwaiger M., and Arnold W. Positron-emission tomography for the preoperative staging of head-andneck tumours. Br J Cancer 77 (1998) 12-19
10. Schiepers C., Penninckx F., and deVadder N. Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 21 (1995) 517-522
11. Steinert H.C., Huch Boni R.A., Buck A., Boni R., Berthold T., Marincek B., Burg G., et al. Malignant melanoma: Staging with whole-body positron emission tomography and 2-[F-18]-Fluoro-2-deoxy-D-glucose. Radiology 195 (1995) 705-709
12. Diederichs C.G., Staib L., Vogel J., Glasbrenner B., Glatting G., Brambs H.J., Beger H.G., et al. Values and limitations of 18F-fluorodeoxyglucose positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20 (2000) 109-116
13. Kluge R., Schmidt F., Caca K., Barthel H., Hesse S., Georgi P., Seese A., Huster D., and Berr F. Positron emission tomography with [18F]fluoro-2-deoxy-D-glucose for Diagnosis and staging of bile duct cancer. Hepatology 33 (2001) 1029-1035
14. Kato T., Tsukamoto E., Kuge Y., Katoh C., Nambu T., Nobuta A., Kondo S., Asaka M., and Tamaki N. Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med 29 (2002) 1047-1054
15. Kawasaki S., Imamura H., and Kobayashi A. Results of surgical resection for patients with hilar bile duct cancer: Application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238 (2003) 84-92
16. Pichlmayr R., Weimann A., and Klempnauer J. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 224 (1996) 628-638
17. Neuhaus P., Jonas S., and Bechstein W.O. Extended resections for hilar cholangiocarcinoma. Ann Surg 230 (1999) 808-818
18. Jarnagin W.R., Fong Y., and DeMatteo R.P. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507-517
19. Witzigmann H., Ringel U., Caca K., Berr F., Uhlmann D., Schoppmeyer K., Tannapfel A., Wittekind C., Mossner J., Hauss J., and Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma. Ann Surg 244 (2006) 230-239
20. Bismuth H., and Corlette M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140 (1975) 170-178
21. Golematis B., Giannopoulos A., Papachristou D.N., and Dreiling D.A. Sclerosing cholangitis of the bifurcation of the common hepatic duct. Am J Gastroenterol 75 (1981) 370-732
22. Smadja C., Bowley N.B., Benjamin I.S., and Blumgart L.H. Idiopathic localized bile duct strictures: Relationship to primary sclerosing cholangitis. Am J Surg 146 (1983) 404-408
23. Standfield N.J., Salisbury J.R., and Howard E.R. Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg 76 (1998) 849-852
24. Baggott B.B., and Long W.B. Annular pancreas as a cause of extrahepatic biliary obstruction. Am J Gastroenterol 86 (1991) 224-226
25. Hadjis N.S., Collier N.A., and Blumgart L.H. Malignant masquerade at the hilum of the liver. Br J Surg 72 (1985) 659-661
26. Herrmann G., Lorenz M., Kirkowa-Reiman M., Hottenrott C., and Hubner K. Morphological changes after intra-arterial chemotherapy of the liver. Hepatogastroenterology 34 (1987) 5-9
27. Feydy A., Vilgrain V., Denys A., Sibert A., Belghiti J., and Vullierme M.P. Helical CT assessment in hilar cholangiocarcinoma: Correlation with surgical and pathologic findings. AJR Am J Roentgenol 172 (1999) 73-77
28. Park M.S., Kim T.K., Kim K.W., Park S.W., Lee J.K., Kim J.S., Lee J.H., Kim K.A., Kim A.Y., Kim P.N., Lee M.G., and Ha J.K. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: Findings at MRCP versus ERCP. Radiology 233 (2004) 234-240
29. Fritscher-Ravens A., Bohuslavizki K.H., Broering D.C., Jenicke L., Schäfer H., Buchert R., Rogiers X., and Clausen M. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22 (2001) 1277-1285
30. Reinhardt M.J., Strunk H., Gerhardt T., Roedel R., Jaeger U., Bucerius J., Sauerbruch T., Biersack H.J., and Dumoulin F.L. Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: Preliminary results for 22 patient studies. J Nucl Med 46 (2005) 1158-1163
31. Rabinovitz M., Zajko A.B., Hassanein T., Shetty B., Bron K.M., Schade R.R., Gavaler J.S., Block G., Van Thiel D.H., and Dekker A. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study of 65 patients with bile duct strictures. Hepatology 12 (1990) 747-752
32. Terasaki K., Wittich G.R., Lycke G., Walter R., Nowels K., Swanson D., and Lucas D. Percutaneous transluminal biopsy of biliary strictures with a bioptome. AJR Am J Roentgenol 156 (1991) 77-78
33. Cullen S.N., and Chapman R.W. Review article: current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 21 (2005) 933-948
34. Brentnall T.A., Chen R., Lee J.G., Kimmey M.B., Bronner M.P., Haggitt R.C., Kowdley K.V., Hecker L.M., and Byrd D.R. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55 (1995) 4264-4267
35. Ahrendt S.A., Eisenberger C.F., Yip L., Rashid A., Chow J.T., Pitt H.A., and Sidransky D. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. J Surg Res 84 (1999) 88-93
36. Tannapfel A., Benicke M., Katalinic A., Uhlmann D., Kockerling F., Hauss J., and Wittekind C. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47 (2000) 721-727
37. Soetikno R.M., Lin O.S., Heidenreich P.A., Young H.S., and Blackstone M.O. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56 (2002) 48-54